Top compounds associated with response to SART3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 5e-09
mRNA ELCPK CTRPv2 pan-cancer AAC 0.21 5e-05
mRNA Crizotinib FIMM pan-cancer AAC 0.22 0.2
mRNA STF-31 CTRPv2 pan-cancer AAC 0.22 6e-09
mRNA Tipifarnib FIMM pan-cancer AAC 0.22 0.09
mRNA Irinotecan CCLE pan-cancer AAC 0.22 7e-05
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.23 5e-11
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 1e-11
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.24 0.02
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.25 3e-11
Download CSV